Mondadori Store

Trova Mondadori Store

Benvenuto
Accedi o registrati

lista preferiti

Per utilizzare la funzione prodotti desiderati devi accedere o registrarti

Vai al carrello
 prodotti nel carrello

Totale  articoli

0,00 € IVA Inclusa

Biologics in Otolaryngology, An Issue of Otolaryngologic Clinics of North America, E-Book


pubblicato da Elsevier Health Sciences

Prezzo online:
66,65
74,04
-10 %
74,04

This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.

Dettagli down

Generi Scienza e Tecnica » Medicina

Editore Elsevier Health Sciences

Formato Ebook con Adobe DRM

Pubblicato 09/07/2021

Lingua Inglese

EAN-13 9780323835374

0 recensioni dei lettori  media voto 0  su  5

Scrivi una recensione per "Biologics in Otolaryngology, An Issue of Otolaryngologic Clinics of North America, E-Book"

Biologics in Otolaryngology, An Issue of Otolaryngologic Clinics of North America, E-Book
 

Accedi o Registrati  per aggiungere una recensione

usa questo box per dare una valutazione all'articolo: leggi le linee guida
torna su Torna in cima